文献速递生殖医学

基于子宫内膜容受性分析指导的个体化胚胎移植:系统综述与荟萃分析

Personalized embryo transfer guided by endometrial receptivity analysis: a systematic review with meta-analysis.
PubMed 文献 · Hum Reprod · 2023-01-01

本系统综述与荟萃分析检索截至2022年10月的文献,纳入35项研究(85%使用ERA),评估TER指导的个体化胚胎移植(pET)对比标准胚胎移植(sET)的效果。在无反复种植失败(RIF)女性中,中等质量证据显示活产率和临床妊娠率无重要差异;在RIF女性中,低质量证据提示pET可能提高临床妊娠率(OR 2.50,95%CI 1.42-4.40)。

要点

  • 无RIF女性中,TER指导的pET与sET相比活产率和临床妊娠率无重要差异(中等质量证据)。
  • RIF女性中,低质量证据提示pET可能提高临床妊娠率(OR 2.50,95%CI 1.42-4.40)。
  • 现有证据不足以支持在无RIF女性中常规使用TER指导的pET。

核心结论

  • 在无RIF女性中,TER指导的pET未证明比sET更有效,现有证据不支持常规使用该策略。
  • 在RIF女性中,来自校正混杂因素的观察性研究的低质量证据提示pET可能提高临床妊娠率,但需要更多研究。
  • 本综述呈现了当前最佳证据,但仍不足以改变现行政策。

研究设计与样本

  • 系统综述与荟萃分析,检索CENTRAL、PubMed、Embase、参考文献列表、临床试验注册库和会议论文集,检索日期为2022年10月,无语言限制。
  • 纳入比较TER指导的pET与sET的随机对照试验(RCT)和队列研究,共筛选2136项研究,纳入35项(85%使用ERA,15%使用其他TER)。
  • 仅低/中度偏倚风险的研究进入荟萃分析,采用Cochrane工具和ROBINS-I评估偏倚风险,采用GRADE方法评价证据确定性。

主要发现

  • 两项RCT比较ERA指导的pET与sET在无RIF女性中的效果,活产率和临床妊娠率无重要差异(中等质量证据)。
  • 四项校正混杂因素的队列研究荟萃分析与RCT一致,在无RIF女性中未发现获益。
  • 在RIF女性中,低质量证据提示pET可能提高临床妊娠率(OR 2.50,95%CI 1.42-4.40)。

关键数值与推荐

  • 无RIF女性:pET与sET相比,活产率和临床妊娠率无重要差异(中等质量证据)。
  • RIF女性:pET可能提高临床妊娠率(OR 2.50,95%CI 1.42-4.40;低质量证据)。

临床怎么用

  • 在无RIF女性中,现有证据不支持常规使用TER指导的pET。
  • 在RIF女性中,低质量证据提示pET可能提高临床妊娠率,但需要更多研究评估潜在获益。
  • 本综述证据仍不足以改变现行政策。

局限性

  • 低偏倚风险的研究很少。
  • 仅有两项RCT在无RIF女性中发表,RIF女性中无RCT发表。
  • 人群、干预、共同干预、结局、比较和操作的异质性限制了多个纳入研究的合并。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Does a personalized embryo transfer (pET) guided by tests for endometrial receptivity (TER) increase the effectiveness of ART procedures? SUMMARY ANSWER: The use of TER-guided pET is not supported by current published evidence in women without repeated implantation failure (RIF), while in women with RIF more research is needed to assess a potential benefit. WHAT IS KNOWN ALREADY: Implantation rates are still far from ideal, especially in some patients that have RIF with good-quality embryos. As a potential solution, a wide range of diverse TER use different sets of genes to identify displacements of the window of implantation to adjust the individual length of progesterone exposure in a pET. STUDY DESIGN, SIZE, DURATION: A systematic review with meta-analysis was performed. Search terms included endometrial receptivity analysis, ERA, personalized embryo transfer. CENTRAL, PubMed, Embase, reference lists, clinical trials registers, and conference proceedings (search date October 2022) were searched, with no language restrictions. PARTICIPANTS/MATERIALS, SETTING, METHODS: Randomized controlled trials (RCTs) and cohort studies comparing a pET guided by TER vs standard embryo transfer (sET) in different subgroups that undergo ART were identified. We also investigated pET in non-receptive-TER vs sET in receptive-TER, and pET in a specific population vs sET in a general population. Risk of bias (RoB) was assessed with the Cochrane tool and ROBINS-I. Only those with low/moderate RoB underwent meta-analysis. The GRADE approach was used to evaluate the certainty of evidence (CoE). MAIN RESULTS AND THE ROLE OF CHANCE: We screened 2136 studies and included 35 (85% used ERA and 15% used other TER). Two studies were RCTs comparing endometrial receptivity analysis (ERA)-guided pET vs sET in women with no history of RIF. In women without RIF, no important differences (moderate-CoE) were found in live birth rates and clinical pregnancy rates (CPR). We also performed a meta-analysis of four cohort studies that were adjusted for confounding. In agreement with the RCTs, no benefits were found in women without RIF. However, in women with RIF, low CoE suggests that pET might improve the CPR (OR 2.50, 95% CI 1.42-4.40). LIMITATIONS, REASONS FOR CAUTION: We found few studies with low RoB. Only two RCTs in women without RIF were published, and none in women with RIF. Furthermore, the heterogeneity observed in populations, interventions, co-interventions, outcomes, comparisons, and procedures limited the pooling of many of the included studies. WIDER IMPLICATIONS OF THE FINDINGS: In the population of women without RIF, in agreement with previously published reviews, pET did not prove to be more effective than sET and, therefore, it precludes the routine use of this strategy in this population until more evidence is available. However, more research is advisable in women with RIF as low-certainty evidence from observational studies adjusted for confounders suggests that the CPR might be higher with pET guided by TER in this population. Although this review presents the best available evidence, it is still insufficient to change current policies. STUDY FUNDING/COMPETING INTEREST(S): No specific funding was obtained for this study. There are no conflicts of interest to declare. REGISTRATION NUMBER: PROSPERO CRD42022299827.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Glujovsky D, Lattes K, Miguens M, et al. Personalized embryo transfer guided by endometrial receptivity analysis: a systematic review with meta-analysis. Hum Reprod. 2023. PMID: 37203432. doi:10.1093/humrep/dead098

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。